The present invention relates to use of pyrimido-diazepinone compounds that are able to modulate protein kinases such as ΡΙ3Κ-γ and PI3K-δ, which are members of the Class I Type IA and Class I Type IB family of phosphatidylinositol- 4,5-bisphosphate 3-kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
本发明涉及使用
嘧啶并
咪唑酮类化合物来调节蛋白激酶,如
PI3K-γ和
PI3K-δ,它们是
磷脂酰肌醇-4,5-双
磷酸3-激酶的IA类和IB类家族成员,以及在治疗各种疾病、疾病或病情中使用此类化合物。